What is Strand Life Sciences Pvt?
Headquartered in Bangalore, Strand Life Sciences Pvt operates at the intersection of advanced computational biology and clinical diagnostics. With over two decades of operational expertise, the firm provides a comprehensive suite of services including Next-Generation Sequencing (NGS), PCR diagnostics, and sophisticated biomarker discovery platforms. Their proprietary software architecture integrates clinical and omics data, enabling pharmaceutical and biotechnology partners to accelerate drug discovery and improve patient outcomes in oncology. By leveraging real-world data and artificial intelligence, Strand Life Sciences bridges the gap between raw genomic information and actionable clinical insights, maintaining rigorous compliance with global healthcare standards.
How much funding has Strand Life Sciences Pvt raised?
Strand Life Sciences Pvt has raised a total of $27.6M across 3 funding rounds:
Series A
$4.6M
Series B
$10M
Private Equity
$13M
Series A (2002): $4.6M with participation from Steamboat Ventures
Series B (2013): $10M, investors not publicly disclosed
Private Equity (2018): $13M supported by HealthQuad and Quadria Capital Investment Management
Key Investors in Strand Life Sciences Pvt
HealthQuad
HealthQuad is India's leading healthcare innovation fund focused on nurturing innovative models that transform healthcare and create an inclusive impact on communities.
Quadria Capital Investment Management
Quadria Capital is a leading private equity firm based in India and Singapore, focused on transforming healthcare in Asia through strategic investments in scalable healthcare companies.
Steamboat Ventures
Steamboat Ventures focuses on helping young companies become market leaders by investing in early to growth stage companies within the technology, media, and consumer sectors.
What's next for Strand Life Sciences Pvt?
With the recent influx of capital, Strand Life Sciences is well-positioned to accelerate its expansion into high-growth markets and further refine its AI-powered diagnostic reporting tools. The strategic focus will likely shift toward deepening its footprint in the pharmaceutical sector, where the demand for precision medicine and biomarker-driven drug development continues to surge. By capitalizing on its established infrastructure and deep domain expertise, the company is poised to lead the next wave of digital health transformation, potentially exploring new frontiers in personalized therapeutic interventions and large-scale genomic data analytics.
See full Strand Life Sciences Pvt company page
